,mean_rank,weight
cervix,6.0,3.0
adrenal gland neuroblastoma,15.0,5.0
adrenal gland,22.0,3.0
vertebra,39.0,2.0
neuroblastoma,44.0,52.0
cervical small cell carcinoma,44.0,1.0
lung carcinoma,46.0,1.0
pancreatic somatostatinoma,47.0,3.0
small cell lung carcinoma,50.5,88.0
right pararenal lymph node,52.5,2.0
prostate carcinoma,59.0,11.0
medulloblastoma,62.5,8.0
embryonal carcinoma,63.0,1.0
endometrioid stromal sarcoma,65.0,3.0
testicular embryonal carcinoma,76.0,1.0
primitive neuroectodermal tumor,82.5,2.0
endometrial carcinoma,95.0,8.0
large cell lung carcinoma,96.0,32.0
gastric adenosquamous carcinoma,96.5,2.0
hereditary thyroid gland medullary carcinoma,102.0,1.0
multiple endocrine neoplasia type 2,102.0,1.0
brain,108.5,16.0
lung carcinoid tumor,110.5,6.0
abdomen,112.5,2.0
"squamous cell breast carcinoma, acantholytic variant",118.0,3.0
gastric small cell neuroendocrine carcinoma,118.5,4.0
skin nodule,120.0,1.0
rhabdoid tumor of the kidney,124.0,3.0
high grade ovarian serous adenocarcinoma,124.5,40.0
lung mucoepidermoid carcinoma,126.0,3.0
not specified,127.0,3.0
myeloid leukemia associated with down syndrome,132.0,1.0
supraclavicular lymph node,132.0,3.0
rhabdomyosarcoma,134.0,4.0
peritoneal ascites,137.0,2.0
thyroid gland squamous cell carcinoma,140.0,3.0
mediastinal lymph node,149.0,1.0
subserosa of fallopian tube,153.0,1.0
ovarian endometrioid adenocarcinoma,155.0,11.0
ewing sarcoma,161.0,31.0
salivary gland squamous cell carcinoma,161.0,3.0
right thigh skin,167.0,2.0
endometrial adenosquamous carcinoma,173.0,6.0
erythroleukemia,174.0,3.0
adrenal cortex carcinoma,176.0,1.0
cervical squamous cell carcinoma,180.0,1.0
embryonal rhabdomyosarcoma,180.5,6.0
uterine carcinosarcoma,183.0,2.0
ovarian carcinoma,187.0,6.0
papillary renal cell carcinoma,198.0,5.0
invasive lobular breast carcinoma,199.0,1.0
gastric fundus carcinoma,203.0,1.0
brca1 syndrome,205.0,1.0
ovarian serous adenocarcinoma,213.0,7.0
osteosarcoma,216.0,23.0
ovarian leiomyosarcoma,217.0,3.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",219.0,2.0
bronchogenic carcinoma,226.5,2.0
alveolar rhabdomyosarcoma,228.0,9.0
mucinous gastric adenocarcinoma,234.0,3.0
squamous cell lung carcinoma,237.0,48.0
undifferentiated gallbladder carcinoma,245.0,1.0
bone marrow,247.0,65.0
burkitt lymphoma,247.0,8.0
childhood acute myeloid leukemia with maturation,250.0,1.0
malignant ovarian brenner tumor,251.0,1.0
ovarian serous cystadenocarcinoma,258.5,4.0
lymphoma,263.0,1.0
lung giant cell carcinoma,264.5,4.0
pharyngeal squamous cell carcinoma,271.0,3.0
childhood t acute lymphoblastic leukemia,272.0,19.0
liposarcoma,273.0,1.0
spleen,275.0,3.0
chronic lymphocytic leukemia,275.0,2.0
ovarian adenocarcinoma,277.0,5.0
thyroid gland follicular carcinoma,280.5,10.0
abdominal wall,288.0,2.0
oligodendroglioma,289.0,5.0
tonsillar squamous cell carcinoma,291.0,1.0
omentum,292.0,7.0
pyriform fossa squamous cell carcinoma,294.0,1.0
ovarian mucinous adenocarcinoma,295.5,4.0
ascites,296.0,103.0
uterine corpus sarcoma,302.0,3.0
bone,307.0,1.0
gastric tubular adenocarcinoma,307.0,11.0
adult b acute lymphoblastic leukemia,309.0,3.0
lung adenocarcinoma,312.0,145.0
skin squamous cell carcinoma,313.0,1.0
breast carcinoma,314.0,27.0
pleural effusion,314.5,224.0
plasma cell myeloma,315.5,30.0
ovarian granulosa cell tumor,316.5,2.0
ovarian cystadenocarcinoma,319.0,6.0
pelvic wall,319.0,3.0
pancreatic carcinoma,322.0,12.0
poorly differentiated thyroid gland carcinoma,324.0,3.0
hypopharyngeal squamous cell carcinoma,332.0,5.0
lymph node,333.0,105.0
thyroid gland undifferentiated (anaplastic) carcinoma,338.0,13.0
natural killer cell lymphoblastic leukemia/lymphoma,342.0,1.0
epithelioid cell type gastrointestinal stromal tumor,344.0,3.0
cutaneous melanoma,350.5,26.0
pleural epithelioid mesothelioma,354.5,18.0
gastric carcinoma,357.0,12.0
esophageal squamous cell carcinoma,358.0,59.0
duodenal adenocarcinoma,359.0,1.0
hodgkin lymphoma,360.0,11.0
cervical lymph node,363.0,5.0
childhood t lymphoblastic lymphoma,366.0,2.0
endometrial adenocarcinoma,369.5,34.0
b-cell non-hodgkin lymphoma,372.0,7.0
"chronic myelogenous leukemia, bcr-abl1 positive",375.5,16.0
cervical carcinoma,379.5,2.0
brachialis muscle,380.0,3.0
peripheral blood,380.0,107.0
axillary lymph node,381.0,6.0
pancreatic adenocarcinoma,382.0,39.0
b-cell prolymphocytic leukemia,383.0,2.0
adult acute monocytic leukemia,384.0,5.0
human papillomavirus-related endocervical adenocarcinoma,384.5,4.0
hepatocellular carcinoma,385.0,51.0
gingival squamous cell carcinoma,385.0,2.0
parotid gland mucoepidermoid carcinoma,386.0,1.0
celiac axis lymph node,386.0,2.0
minimally invasive lung adenocarcinoma,386.0,16.0
right anterior leg,387.0,3.0
glioblastoma,389.0,84.0
melanoma,389.5,94.0
meninges,390.0,1.0
intrahepatic cholangiocarcinoma,390.0,6.0
acute myelomonocytic leukemia,390.0,1.0
diffuse large b-cell lymphoma germinal center b-cell type,391.0,8.0
inguinal lymph node,392.0,3.0
marek disease,395.0,1.0
childhood acute myeloid leukemia,395.5,2.0
adenosquamous lung carcinoma,396.0,9.0
subcutaneous,397.0,7.0
oral cavity squamous cell carcinoma,399.0,6.0
peritoneal effusion,399.0,6.0
renal cell carcinoma,400.0,37.0
b acute lymphoblastic leukemia,401.0,5.0
askin tumor,401.5,2.0
bladder carcinoma,403.0,51.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),403.5,4.0
diffuse large b-cell lymphoma activated b-cell type,405.0,1.0
n/a,406.0,34.0
"invasive ductal carcinoma, not otherwise specified",412.5,30.0
laryngeal squamous cell carcinoma,415.5,12.0
mantle cell lymphoma,416.5,6.0
gastric adenocarcinoma,417.5,26.0
cerebrospinal fluid,420.0,3.0
intraperitoneal,421.0,1.0
ovarian mucinous cystadenocarcinoma,421.5,2.0
recurrent bladder carcinoma,423.0,3.0
ovarian mixed germ cell tumor,424.0,1.0
non-small cell lung carcinoma,425.5,24.0
groin lymph node,426.0,5.0
anaplastic large cell lymphoma,427.0,8.0
acute myeloid leukemia,427.0,1.0
adult t acute lymphoblastic leukemia,429.0,5.0
hepatoblastoma,429.5,4.0
ovarian clear cell adenocarcinoma,430.0,13.0
squamous papilloma,430.0,1.0
ductal breast carcinoma,430.0,32.0
left supraclavicular lymph node,430.5,4.0
liver,430.5,32.0
lung,433.0,7.0
peritoneum,435.0,1.0
neurofibromatosis type 1,437.0,1.0
pancreatic ductal adenocarcinoma,438.0,39.0
vulvar carcinoma,439.0,1.0
epstein-barr virus-related burkitt lymphoma,439.5,10.0
rectal adenocarcinoma,440.0,11.0
adult acute myeloid leukemia,441.0,22.0
mycosis fungoides and sezary syndrome,441.0,2.0
breast adenocarcinoma,443.0,23.0
gallbladder carcinoma,444.0,2.0
myelodysplastic syndrome,446.0,1.0
primary effusion lymphoma,450.0,3.0
uterine corpus leiomyosarcoma,453.0,3.0
colon adenocarcinoma,456.0,61.0
childhood b acute lymphoblastic leukemia,456.0,9.0
pancreatic adenosquamous carcinoma,458.0,5.0
mediastinal (thymic) large b-cell lymphoma,458.0,1.0
rectosigmoid adenocarcinoma,467.0,3.0
gastric choriocarcinoma,468.0,1.0
cecum adenocarcinoma,471.5,18.0
supra-orbital region,472.0,1.0
bladder squamous cell carcinoma,477.0,3.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,478.0,3.0
fibrosarcoma,479.0,5.0
hereditary spherocytosis,480.0,1.0
colon carcinoma,482.0,19.0
tongue squamous cell carcinoma,482.5,34.0
ampulla of vater adenocarcinoma,485.0,2.0
small intestine,486.0,1.0
pelvis; innominate bone,488.5,2.0
brca2 syndrome,495.0,1.0
vulvar melanoma,498.0,1.0
amelanotic melanoma,499.0,16.0
diffuse large b-cell lymphoma,505.5,20.0
splenic lymphoma with circulating villous lymphocytes,507.0,1.0
obturator lymph node,507.0,3.0
down syndrome,509.5,2.0
skin,516.0,3.0
signet ring cell gastric adenocarcinoma,524.0,9.0
undifferentiated pleomorphic sarcoma,526.0,4.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",527.0,2.0
pericardial effusion,528.0,8.0
cutaneous t-cell non-hodgkin lymphoma,531.5,2.0
hilar cholangiocarcinoma,536.0,1.0
esophageal adenocarcinoma,537.0,9.0
astrocytoma,542.0,19.0
buttock,543.0,2.0
clear cell renal cell carcinoma,554.0,18.0
left leg muscle,554.0,3.0
benign prostatic hyperplasia,563.0,1.0
barrett adenocarcinoma,576.0,3.0
hairy cell leukemia,582.0,3.0
familial adenomatous polyposis,583.0,1.0
thigh skin,585.0,1.0
pleural sarcomatoid mesothelioma,586.0,8.0
lymphoblastic lymphoma,587.0,1.0
pleural biphasic mesothelioma,597.0,7.0
chondrosarcoma,597.5,10.0
subcutaneous; right buttock,598.0,3.0
human papillomavirus-related cervical squamous cell carcinoma,603.0,8.0
vaginal melanoma,604.0,1.0
vulvar leiomyosarcoma,605.0,3.0
paragastric lymph node,624.0,2.0
biphasic synovial sarcoma,629.0,1.0
papillary lung adenocarcinoma,631.0,3.0
ovary,635.0,1.0
oral dysplasia,638.0,1.0
"chronic eosinophilic leukemia, not otherwise specified",649.0,1.0
buccal mucosa squamous cell carcinoma,654.5,2.0
childhood acute monocytic leukemia,670.0,2.0
mandible,674.0,1.0
cystic fibrosis,705.5,2.0
anaplastic astrocytoma,707.0,5.0
cholangiocarcinoma,720.0,2.0
head and neck squamous cell carcinoma,729.0,9.0
thyroid gland sarcoma,738.0,1.0
floor of mouth squamous cell carcinoma,739.0,1.0
gliosarcoma,740.0,6.0
thoracic lymph duct,747.0,1.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,762.0,1.0
gestational choriocarcinoma,783.5,2.0
vulvar squamous cell carcinoma,787.0,3.0
pleural malignant mesothelioma,791.0,5.0
follicular lymphoma,792.0,2.0
right axillary lymph node,802.0,1.0
left cervical lymph node,875.0,1.0
thyroid gland papillary carcinoma,875.0,1.0
squamous cell carcinoma,883.0,1.0
epithelioid sarcoma,957.0,1.0
